Open AccessJournal Article
Long-term survival.
Cho Yw,Terasaki Pi +1 more
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.Abstract:
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.read more
Citations
More filters
Journal ArticleDOI
II Diretrizes da Sociedade Brasileira de Cardiologia Sobre Teste Ergométrico
Fábio Sândoli de Brito,Fábio Vilas-Boas,Iran Castro,Japy Angelin de Oliveira,Jorge Ilha Guimarães,Ricardo Stein,Álvaro Bellini,Antonio Felipe Simão,Artur Haddad Herdy,Japy Angelin Filho,Paulo Roberto Pereira Toscano,Ricardo Quental Coutinho,Augusto Heitor Xavier de Brito,Heloísa Borges,Luis E. Mastrocolla,Nabyl Ghorayeb,Ricardo Vivacqua,Mauricio Batista Nunes,Godoy M,Salvador Manoel Serra,Roberto Alfieri,Jorge Pinto Ribeiro,Salvador Ramos,Washington Araújo,José Nolasco,Romeu Meneghello,William Azem Chalela,Claudio Gil Soares de Araújo,Paulo Yazbeck,Claudio Gil Soares Araújo,Marianna Andrade +30 more
Journal ArticleDOI
Secondary health complications in an aging Canadian spinal cord injury sample.
Sander L. Hitzig,Mark I. Tonack,Kent A. Campbell,Colleen F. McGillivray,Kathryn A. Boschen,Kieva Richards,B C Craven +6 more
TL;DR: The findings provide some clarification on factors associated with the occurrence of secondary health complications after SCI and are useful for informing health-promotion planners, clinicians, and stakeholders regarding the odds of SHCs with aging or among specific impairment groups.
Journal ArticleDOI
The health status of adult survivors of cancer in childhood
TL;DR: Data support the need for the continuing follow-up of survivors of cancer in childhood into adult life and the provision of the resources to do so, as more than half have at least one chronic medical problem and demonstrate a significant use of medical resources.